top of page


Spin off company from the Centre for Genomic Regulation
(Barcelona - Spain) founded by experienced entrepreneurs and funded

Pulmobiotics will use its unique and protected genetic toolkit to develop novel live biotherapeutics for the treatment of respiratory diseases
Global causes of death
A new delivery sytem to provide solutions
for different lung diseases.
Respiratory diseases are among the most common causes
of severe illness and death worldwide.
Ischaemic heart disease
Respiratory disease *
Stroke
Neonatal conditions
Alzheimer / Other dementias
Diarrhoeal disease
Diabetes mellitus
Kidney disease
Cirrhosis of the liver
Road injury
0
20
40
60
Respiratory Crude death rate (per 10.000 population)
80
100
120
* Respiratory diseases include COPD, Lower respiratory infections, and cancers (trachea, bronchus and lung)

Pulmobiotics’ genome editing tools can be adapted to modify
the genome of different bacteria
bottom of page